(Q44297695)

English

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis (English)

1 reference

Europe PubMed Central

1 December 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

author name string

Birgül Vanizor Kural

1

1 reference

Europe PubMed Central

1 December 2017

Asim Orem

2

1 reference

Europe PubMed Central

1 December 2017

Gülseren Cimşit

3

1 reference

Europe PubMed Central

1 December 2017

Yunus Emre Yandi

4

1 reference

Europe PubMed Central

1 December 2017

Mustafa Calapoglu

5

1 reference

Europe PubMed Central

1 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

1 December 2017

Clinica Chimica Acta

1 reference

Europe PubMed Central

1 December 2017

328

1 reference

Europe PubMed Central

1 December 2017

1-2

1 reference

Europe PubMed Central

1 December 2017

71-82

1 reference

Europe PubMed Central

1 December 2017

Recent developments in the understanding of the pathogenesis of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Redox-modulated pathways in inflammatory skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Oxidative stress induced in pathologies: the role of antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Physiological aspects of low-density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Metabolism of oxidized LDL by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Is oxidized low‐density lipoprotein present in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Assessment of disease progress in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Fast separation of the three main plasma lipoprotein classes by ultracentrifugation using vertical rotor and multiple discontinuous density gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Correlation between susceptibility of LDL subfractions to in vitro oxidation and in vivo oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

The Autoxidation of Human Red Cell Lipids Induced by Hydrogen Peroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

A new sensitive assay for the measurement of hydroperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Catalase in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Plasma lipid changes in psoriatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Serum lipid and apolipoprotein levels in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Serum levels of apolipoproteins AI, AII and B in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Oxidation of low density lipoproteins from patients with renal failure or renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Oxidized LDL, diet, and natural antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Clinical significance of antibodies against oxidised low density lipoprotein in early RA.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Inflammation-mediated rheumatic diseases and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

The relationship of oxidized lipids to coronary artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Stress, inflammation and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Skin antioxidants: their role in aging and in oxidative stress--new approaches for their evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Circulating immune complexes, serum immunoglobulins, and acute phase proteins in psoriasis and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

The variation of serum lipoprotein (a) level with disease activity in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Antioxidants and lipid peroxidation status in the blood of patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Erythrocyte glutathione peroxidase activity and plasma vitamin E status in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Antioxidant enzymes in psoriatic fibroblasts and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900373-X

7 January 2021

Identifiers

10.1016/S0009-8981(02)00373-X

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44297695&oldid=2109258462"